HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pityriasis rubra pilaris successfully treated with infliximab.

AuthorsDiana P Ruiz-Genao, Jose Luis Lopez-Estebaranz, Elena Naz-Villalba, Reyes Gamo-Villegas, Leticia Calzado-Villarreal, Fernando Pinedo-Moraleda
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 87 Issue 6 Pg. 552-3 ( 2007) ISSN: 0001-5555 [Print] Sweden
PMID17989902 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Infliximab
  • Infusions, Intravenous
  • Middle Aged
  • Pityriasis Rubra Pilaris (drug therapy, pathology)
  • Skin (pathology)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: